Analgesics in Finland

Analgesics in Finland

  • September 2016
  • 26 pages
  • Euromonitor International
Report ID: 165058
The overall value of analgesics grew by 2% in current value terms. The improvement in the growth rate was partly facilitated by two new analgesics becoming available in Finland. Naproxen (up to 10 tablets) was switched to OTC in December 2015 and adult OTC triptans in January 2016. As of mid-2016, only two brands had obtained the sales permit limiting sales volume, but more brands were expected to enter in the near future.

Euromonitor International’s Analgesics in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=Finland Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000